nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CA6—submandibular gland—salivary gland cancer	0.123	0.396	CbGeAlD
Celecoxib—CA6—ear—salivary gland cancer	0.0404	0.13	CbGeAlD
Celecoxib—MAPK14—neck—salivary gland cancer	0.0126	0.0407	CbGeAlD
Celecoxib—PDPK1—lymphoid tissue—salivary gland cancer	0.0124	0.0399	CbGeAlD
Celecoxib—CA6—parotid gland—salivary gland cancer	0.0116	0.0375	CbGeAlD
Celecoxib—CA6—saliva-secreting gland—salivary gland cancer	0.0112	0.0359	CbGeAlD
Celecoxib—MAPK14—connective tissue—salivary gland cancer	0.00906	0.0292	CbGeAlD
Celecoxib—MAPK14—epithelium—salivary gland cancer	0.0086	0.0277	CbGeAlD
Celecoxib—PDPK1—lymph node—salivary gland cancer	0.00699	0.0225	CbGeAlD
Celecoxib—CA12—connective tissue—salivary gland cancer	0.00687	0.0221	CbGeAlD
Celecoxib—MAPK14—lymphoid tissue—salivary gland cancer	0.00662	0.0213	CbGeAlD
Celecoxib—CA4—neck—salivary gland cancer	0.00594	0.0191	CbGeAlD
Celecoxib—CA2—neck—salivary gland cancer	0.00492	0.0159	CbGeAlD
Celecoxib—CA4—parotid gland—salivary gland cancer	0.00483	0.0156	CbGeAlD
Celecoxib—CA4—saliva-secreting gland—salivary gland cancer	0.00463	0.0149	CbGeAlD
Celecoxib—CA2—parotid gland—salivary gland cancer	0.00401	0.0129	CbGeAlD
Celecoxib—CA2—saliva-secreting gland—salivary gland cancer	0.00384	0.0124	CbGeAlD
Celecoxib—MAPK14—lymph node—salivary gland cancer	0.00374	0.012	CbGeAlD
Celecoxib—CA2—connective tissue—salivary gland cancer	0.00353	0.0114	CbGeAlD
Celecoxib—CA2—epithelium—salivary gland cancer	0.00335	0.0108	CbGeAlD
Celecoxib—PTGS2—connective tissue—salivary gland cancer	0.0026	0.00839	CbGeAlD
Celecoxib—CA2—lymphoid tissue—salivary gland cancer	0.00258	0.00831	CbGeAlD
Celecoxib—CA5B—lymph node—salivary gland cancer	0.00254	0.00819	CbGeAlD
Celecoxib—PTGS2—epithelium—salivary gland cancer	0.00247	0.00796	CbGeAlD
Celecoxib—ORM1—lymph node—salivary gland cancer	0.00225	0.00724	CbGeAlD
Celecoxib—ALB—lymph node—salivary gland cancer	0.00197	0.00635	CbGeAlD
Celecoxib—ABCC4—lymph node—salivary gland cancer	0.00191	0.00615	CbGeAlD
Celecoxib—PTGS2—lymphoid tissue—salivary gland cancer	0.0019	0.00613	CbGeAlD
Celecoxib—CA4—lymph node—salivary gland cancer	0.00176	0.00565	CbGeAlD
Celecoxib—CA2—lymph node—salivary gland cancer	0.00146	0.00469	CbGeAlD
Celecoxib—PTGS2—lymph node—salivary gland cancer	0.00107	0.00346	CbGeAlD
Celecoxib—PDPK1—Immune System—MAP2K2—salivary gland cancer	0.000181	0.000263	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NUP62—salivary gland cancer	0.00018	0.000261	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NUP62—salivary gland cancer	0.000179	0.00026	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—EP300—salivary gland cancer	0.000175	0.000253	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—JAG1—salivary gland cancer	0.000174	0.000252	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—FGFR4—salivary gland cancer	0.000173	0.000251	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAML3—salivary gland cancer	0.000172	0.00025	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—salivary gland cancer	0.000171	0.000249	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—FBXW7—salivary gland cancer	0.00017	0.000247	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—HRAS—salivary gland cancer	0.00017	0.000246	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MARCKS—salivary gland cancer	0.00017	0.000246	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—PIK3CA—salivary gland cancer	0.000169	0.000245	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ISYNA1—salivary gland cancer	0.000168	0.000244	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MC3R—salivary gland cancer	0.000168	0.000244	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MAP2K2—salivary gland cancer	0.000167	0.000243	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—HRAS—salivary gland cancer	0.000167	0.000242	CbGpPWpGaD
Celecoxib—CA14—Metabolism—CREBBP—salivary gland cancer	0.000165	0.000239	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—PTEN—salivary gland cancer	0.000165	0.000239	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MAML2—salivary gland cancer	0.000162	0.000236	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000162	0.000235	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MAP2K2—salivary gland cancer	0.000162	0.000234	CbGpPWpGaD
Celecoxib—CA6—Metabolism—CREBBP—salivary gland cancer	0.000161	0.000233	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CREBBP—salivary gland cancer	0.000161	0.000233	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—PTEN—salivary gland cancer	0.000158	0.00023	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PYGB—salivary gland cancer	0.000158	0.000229	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—EP300—salivary gland cancer	0.000157	0.000228	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—salivary gland cancer	0.000157	0.000228	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—HRAS—salivary gland cancer	0.000156	0.000226	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—HRAS—salivary gland cancer	0.000155	0.000224	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000154	0.000223	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—EP300—salivary gland cancer	0.000153	0.000222	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—CREBBP—salivary gland cancer	0.000152	0.000221	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—PTEN—salivary gland cancer	0.00015	0.000218	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—CREBBP—salivary gland cancer	0.00015	0.000218	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SMC1A—salivary gland cancer	0.00015	0.000218	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—NOTCH1—salivary gland cancer	0.00015	0.000217	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.000149	0.000216	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ST3GAL4—salivary gland cancer	0.000148	0.000214	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DTX4—salivary gland cancer	0.000147	0.000213	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000146	0.000212	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—salivary gland cancer	0.000145	0.00021	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—FOXO3—salivary gland cancer	0.000143	0.000208	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000142	0.000205	CbGpPWpGaD
Celecoxib—CA12—Metabolism—CREBBP—salivary gland cancer	0.000139	0.000202	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	0.000139	0.000201	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—FGFR4—salivary gland cancer	0.000139	0.000201	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000138	0.0002	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ISYNA1—salivary gland cancer	0.000138	0.0002	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000137	0.000199	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MARCKS—salivary gland cancer	0.000137	0.000199	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NOTCH1—salivary gland cancer	0.000137	0.000199	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—FBXW7—salivary gland cancer	0.000137	0.000198	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CREBBP—salivary gland cancer	0.000136	0.000197	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CREBBP—salivary gland cancer	0.000135	0.000195	CbGpPWpGaD
Celecoxib—PTGS2—Disease—DTX4—salivary gland cancer	0.000134	0.000194	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CDH1—salivary gland cancer	0.000134	0.000194	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—CREBBP—salivary gland cancer	0.000133	0.000193	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—salivary gland cancer	0.000133	0.000193	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000133	0.000192	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000132	0.000191	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.00013	0.000189	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—PIK3CA—salivary gland cancer	0.000129	0.000187	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PHGDH—salivary gland cancer	0.000128	0.000186	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000128	0.000185	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PYGB—salivary gland cancer	0.000128	0.000185	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000126	0.000183	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—salivary gland cancer	0.000125	0.000181	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CREBBP—salivary gland cancer	0.000124	0.00018	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ST3GAL4—salivary gland cancer	0.000124	0.000179	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FGF16—salivary gland cancer	0.000122	0.000176	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CREBBP—salivary gland cancer	0.00012	0.000174	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—HRAS—salivary gland cancer	0.00012	0.000173	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTEN—salivary gland cancer	0.000118	0.000171	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000117	0.00017	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—PIK3CA—salivary gland cancer	0.000116	0.000169	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—FOXO3—salivary gland cancer	0.000115	0.000167	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTEN—salivary gland cancer	0.000115	0.000167	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTEN—salivary gland cancer	0.000115	0.000167	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MARCKS—salivary gland cancer	0.000113	0.000164	CbGpPWpGaD
Celecoxib—CA14—Metabolism—EP300—salivary gland cancer	0.000112	0.000163	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AQP1—salivary gland cancer	0.000112	0.000163	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MARCKS—salivary gland cancer	0.000112	0.000163	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000112	0.000162	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FGF16—salivary gland cancer	0.000111	0.000161	CbGpPWpGaD
Celecoxib—CA4—Metabolism—CREBBP—salivary gland cancer	0.000111	0.000161	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—EP300—salivary gland cancer	0.000109	0.000159	CbGpPWpGaD
Celecoxib—CA6—Metabolism—EP300—salivary gland cancer	0.000109	0.000159	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—salivary gland cancer	0.000109	0.000159	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—HRAS—salivary gland cancer	0.000108	0.000156	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTEN—salivary gland cancer	0.000107	0.000155	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NUP62—salivary gland cancer	0.000106	0.000154	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CREBBP—salivary gland cancer	0.000106	0.000154	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—PIK3CA—salivary gland cancer	0.000106	0.000154	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAML2—salivary gland cancer	0.000106	0.000153	CbGpPWpGaD
Celecoxib—PTGS2—Disease—VCAN—salivary gland cancer	0.000106	0.000153	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PYGB—salivary gland cancer	0.000105	0.000153	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PYGB—salivary gland cancer	0.000104	0.000151	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PHGDH—salivary gland cancer	0.000104	0.000151	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—EP300—salivary gland cancer	0.000104	0.00015	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HRAS—salivary gland cancer	0.000103	0.00015	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—EP300—salivary gland cancer	0.000102	0.000148	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ST3GAL4—salivary gland cancer	0.0001	0.000145	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTEN—salivary gland cancer	9.93e-05	0.000144	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—HRAS—salivary gland cancer	9.81e-05	0.000142	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAML2—salivary gland cancer	9.63e-05	0.00014	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—PTEN—salivary gland cancer	9.61e-05	0.000139	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOTCH1—salivary gland cancer	9.59e-05	0.000139	CbGpPWpGaD
Celecoxib—CA12—Metabolism—EP300—salivary gland cancer	9.47e-05	0.000137	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAP2K2—salivary gland cancer	9.41e-05	0.000136	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	9.36e-05	0.000136	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EP300—salivary gland cancer	9.26e-05	0.000134	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EP300—salivary gland cancer	9.16e-05	0.000133	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AQP1—salivary gland cancer	9.09e-05	0.000132	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	9.08e-05	0.000132	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—EP300—salivary gland cancer	9.08e-05	0.000132	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	9.05e-05	0.000131	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JAG1—salivary gland cancer	9.02e-05	0.000131	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FGFR4—salivary gland cancer	8.98e-05	0.00013	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CREBBP—salivary gland cancer	8.96e-05	0.00013	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NUP62—salivary gland cancer	8.91e-05	0.000129	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTEN—salivary gland cancer	8.87e-05	0.000129	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—VCAN—salivary gland cancer	8.84e-05	0.000128	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FBXW7—salivary gland cancer	8.83e-05	0.000128	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CREBBP—salivary gland cancer	8.7e-05	0.000126	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PHGDH—salivary gland cancer	8.58e-05	0.000124	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PTEN—salivary gland cancer	8.57e-05	0.000124	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PHGDH—salivary gland cancer	8.51e-05	0.000123	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EP300—salivary gland cancer	8.46e-05	0.000123	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PIK3CA—salivary gland cancer	8.31e-05	0.000121	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	8.26e-05	0.00012	CbGpPWpGaD
Celecoxib—PTGS2—Disease—JAG1—salivary gland cancer	8.23e-05	0.000119	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FGFR4—salivary gland cancer	8.19e-05	0.000119	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ST3GAL4—salivary gland cancer	8.19e-05	0.000119	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EP300—salivary gland cancer	8.18e-05	0.000119	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—PIK3CA—salivary gland cancer	8.17e-05	0.000118	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PIK3CA—salivary gland cancer	8.1e-05	0.000117	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PIK3CA—salivary gland cancer	8.1e-05	0.000117	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FBXW7—salivary gland cancer	8.06e-05	0.000117	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTEN—salivary gland cancer	7.92e-05	0.000115	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	7.75e-05	0.000112	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—PIK3CA—salivary gland cancer	7.67e-05	0.000111	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NOTCH1—salivary gland cancer	7.67e-05	0.000111	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTEN—salivary gland cancer	7.59e-05	0.00011	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PIK3CA—salivary gland cancer	7.56e-05	0.00011	CbGpPWpGaD
Celecoxib—CA4—Metabolism—EP300—salivary gland cancer	7.55e-05	0.00011	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AQP1—salivary gland cancer	7.5e-05	0.000109	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FOXO3—salivary gland cancer	7.45e-05	0.000108	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AQP1—salivary gland cancer	7.44e-05	0.000108	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—salivary gland cancer	7.42e-05	0.000108	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—PIK3CA—salivary gland cancer	7.42e-05	0.000108	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MARCKS—salivary gland cancer	7.4e-05	0.000107	CbGpPWpGaD
Celecoxib—CA2—Metabolism—EP300—salivary gland cancer	7.24e-05	0.000105	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NUP62—salivary gland cancer	7.21e-05	0.000105	CbGpPWpGaD
Celecoxib—ALB—Metabolism—VCAN—salivary gland cancer	7.15e-05	0.000104	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—HRAS—salivary gland cancer	7.1e-05	0.000103	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PIK3CA—salivary gland cancer	7e-05	0.000102	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CREBBP—salivary gland cancer	6.99e-05	0.000101	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—CREBBP—salivary gland cancer	6.95e-05	0.000101	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDH1—salivary gland cancer	6.94e-05	0.000101	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—CREBBP—salivary gland cancer	6.89e-05	9.99e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PYGB—salivary gland cancer	6.88e-05	9.98e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HRAS—salivary gland cancer	6.86e-05	9.95e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FOXO3—salivary gland cancer	6.8e-05	9.86e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—PIK3CA—salivary gland cancer	6.78e-05	9.83e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	6.74e-05	9.77e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—PIK3CA—salivary gland cancer	6.72e-05	9.74e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—salivary gland cancer	6.5e-05	9.42e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCND1—salivary gland cancer	6.44e-05	9.33e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTEN—salivary gland cancer	6.4e-05	9.28e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—HRAS—salivary gland cancer	6.34e-05	9.19e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	6.27e-05	9.1e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HRAS—salivary gland cancer	6.27e-05	9.1e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PIK3CA—salivary gland cancer	6.26e-05	9.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HRAS—salivary gland cancer	6.21e-05	9.01e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PTEN—salivary gland cancer	6.21e-05	9.01e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—EP300—salivary gland cancer	6.1e-05	8.85e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAP2K2—salivary gland cancer	6.08e-05	8.82e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PIK3CA—salivary gland cancer	6.05e-05	8.77e-05	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	5.97e-05	8.65e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NUP62—salivary gland cancer	5.95e-05	8.63e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EP300—salivary gland cancer	5.92e-05	8.59e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—VCAN—salivary gland cancer	5.9e-05	8.56e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NUP62—salivary gland cancer	5.9e-05	8.55e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—VCAN—salivary gland cancer	5.85e-05	8.49e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HRAS—salivary gland cancer	5.79e-05	8.4e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PHGDH—salivary gland cancer	5.61e-05	8.14e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HRAS—salivary gland cancer	5.6e-05	8.11e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PIK3CA—salivary gland cancer	5.59e-05	8.1e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAP2K2—salivary gland cancer	5.55e-05	8.05e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	5.54e-05	8.03e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	5.4e-05	7.83e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PIK3CA—salivary gland cancer	5.36e-05	7.77e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	5.28e-05	7.66e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	5.14e-05	7.45e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PTEN—salivary gland cancer	4.99e-05	7.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOTCH1—salivary gland cancer	4.99e-05	7.23e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AQP1—salivary gland cancer	4.91e-05	7.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EP300—salivary gland cancer	4.76e-05	6.91e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—EP300—salivary gland cancer	4.69e-05	6.81e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOTCH1—salivary gland cancer	4.55e-05	6.6e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CREBBP—salivary gland cancer	4.52e-05	6.56e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PIK3CA—salivary gland cancer	4.51e-05	6.55e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	4.48e-05	6.5e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PIK3CA—salivary gland cancer	4.38e-05	6.36e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	4.27e-05	6.2e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—salivary gland cancer	4.24e-05	6.15e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CREBBP—salivary gland cancer	4.12e-05	5.98e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRAS—salivary gland cancer	4.05e-05	5.88e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	3.91e-05	5.67e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NUP62—salivary gland cancer	3.89e-05	5.64e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—VCAN—salivary gland cancer	3.86e-05	5.6e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	3.67e-05	5.32e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PIK3CA—salivary gland cancer	3.52e-05	5.11e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	3.5e-05	5.07e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PIK3CA—salivary gland cancer	3.47e-05	5.04e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CREBBP—salivary gland cancer	3.45e-05	5.01e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—salivary gland cancer	3.36e-05	4.87e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCND1—salivary gland cancer	3.34e-05	4.85e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HRAS—salivary gland cancer	3.26e-05	4.73e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTEN—salivary gland cancer	3.23e-05	4.68e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HRAS—salivary gland cancer	3.21e-05	4.66e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	3.16e-05	4.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EP300—salivary gland cancer	3.08e-05	4.46e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PTEN—salivary gland cancer	2.94e-05	4.27e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EP300—salivary gland cancer	2.81e-05	4.07e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CREBBP—salivary gland cancer	2.79e-05	4.05e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	2.59e-05	3.75e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PTEN—salivary gland cancer	2.47e-05	3.58e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—EP300—salivary gland cancer	2.35e-05	3.41e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CREBBP—salivary gland cancer	2.31e-05	3.35e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CREBBP—salivary gland cancer	2.29e-05	3.32e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PIK3CA—salivary gland cancer	2.28e-05	3.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—salivary gland cancer	2.2e-05	3.2e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRAS—salivary gland cancer	2.11e-05	3.06e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PIK3CA—salivary gland cancer	2.08e-05	3.01e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTEN—salivary gland cancer	2e-05	2.89e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HRAS—salivary gland cancer	1.92e-05	2.79e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—EP300—salivary gland cancer	1.9e-05	2.76e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3CA—salivary gland cancer	1.74e-05	2.52e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTEN—salivary gland cancer	1.65e-05	2.39e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTEN—salivary gland cancer	1.63e-05	2.37e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—EP300—salivary gland cancer	1.57e-05	2.28e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—EP300—salivary gland cancer	1.56e-05	2.26e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CREBBP—salivary gland cancer	1.51e-05	2.19e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3CA—salivary gland cancer	1.41e-05	2.04e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	1.16e-05	1.69e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3CA—salivary gland cancer	1.15e-05	1.67e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTEN—salivary gland cancer	1.08e-05	1.56e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—EP300—salivary gland cancer	1.03e-05	1.49e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	7.6e-06	1.1e-05	CbGpPWpGaD
